These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 9274976

  • 41. New selective and potent 5-HT(1B/1D) antagonists: chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides.
    Liao Y, Böttcher H, Harting J, Greiner H, van Amsterdam C, Cremers T, Sundell S, März J, Rautenberg W, Wikström H.
    J Med Chem; 2000 Feb 10; 43(3):517-25. PubMed ID: 10669578
    [Abstract] [Full Text] [Related]

  • 42. No involvement of 5-HT(7) or 5-HT(1D) receptors in the (R)-8-OH-DPAT-induced depression of the monosynaptic reflex in spinalized rats.
    Honda M, Ono H.
    Eur J Pharmacol; 2001 Sep 14; 427(2):125-9. PubMed ID: 11557264
    [Abstract] [Full Text] [Related]

  • 43. Could the 5-HT1B receptor inverse agonism affect learning consolidation?
    Meneses A.
    Neurosci Biobehav Rev; 2001 Mar 14; 25(2):193-201. PubMed ID: 11323083
    [Abstract] [Full Text] [Related]

  • 44. 5-hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: importance of the 5-HT1B receptor.
    Morecroft I, Heeley RP, Prentice HM, Kirk A, MacLean MR.
    Br J Pharmacol; 1999 Oct 14; 128(3):730-4. PubMed ID: 10516655
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Differences in the effects of ketanserin and GR127935 on 5-HT-receptor mediated responses in rabbit saphenous vein and guinea-pig jugular vein.
    Razzaque Z, Longmore J, Hill RG.
    Eur J Pharmacol; 1995 Sep 05; 283(1-3):199-206. PubMed ID: 7498311
    [Abstract] [Full Text] [Related]

  • 47. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats.
    Jeong CY, Choi JI, Yoon MH.
    Eur J Pharmacol; 2004 Oct 19; 502(3):205-11. PubMed ID: 15476746
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Zolmitriptan stimulates a Ca(2+)-dependent K(+) current in C6 glioma cells stably expressing recombinant human 5-HT(1B) receptors.
    Le Grand B, Panissié A, Perez M, Pauwels PJ, John GW.
    Eur J Pharmacol; 2000 Jun 02; 397(2-3):297-302. PubMed ID: 10844127
    [Abstract] [Full Text] [Related]

  • 50. Ketanserin-sensitive depressant actions of 5-HT receptor agonists in the neonatal rat spinal cord.
    Manuel NA, Wallis DI, Crick H.
    Br J Pharmacol; 1995 Nov 02; 116(6):2647-54. PubMed ID: 8590984
    [Abstract] [Full Text] [Related]

  • 51. Role of 5-HT(1B) receptors in the sensitization to amphetamine in mice.
    Przegalinski E, Siwanowicz J, Nowak E, Papla I, Filip M.
    Eur J Pharmacol; 2001 Jun 22; 422(1-3):91-9. PubMed ID: 11430919
    [Abstract] [Full Text] [Related]

  • 52. GR 127935 reduces basal locomotor activity and prevents RU 24969-, but not D-amphetamine-induced hyperlocomotion, in the Wistar-Kyoto hyperactive (WKHA) rat.
    Chaouloff F, Courvoisier H, Moisan MP, Mormède P.
    Psychopharmacology (Berl); 1999 Jan 22; 141(3):326-31. PubMed ID: 10027515
    [Abstract] [Full Text] [Related]

  • 53. Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis.
    Cutrer FM, Yu XJ, Ayata G, Moskowitz MA, Waeber C.
    Neuropharmacology; 1999 Jul 22; 38(7):1043-53. PubMed ID: 10428423
    [Abstract] [Full Text] [Related]

  • 54. SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor.
    Middlemiss DN, Göthert M, Schlicker E, Scott CM, Selkirk JV, Watson J, Gaster LM, Wyman P, Riley G, Price GW.
    Eur J Pharmacol; 1999 Jun 30; 375(1-3):359-65. PubMed ID: 10443589
    [Abstract] [Full Text] [Related]

  • 55. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).
    Martin GR, Robertson AD, MacLennan SJ, Prentice DJ, Barrett VJ, Buckingham J, Honey AC, Giles H, Moncada S.
    Br J Pharmacol; 1997 May 30; 121(2):157-64. PubMed ID: 9154322
    [Abstract] [Full Text] [Related]

  • 56. Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test.
    Tatarczyńska E, Kłodzińska A, Stachowicz K, Chojnacka-Wójcik E.
    Eur J Pharmacol; 2004 Mar 08; 487(1-3):133-42. PubMed ID: 15033385
    [Abstract] [Full Text] [Related]

  • 57. RU 24969, a 5-HT1A/1B agonist, elevates brain stimulation reward thresholds: an effect reversed by GR 127935, a 5-HT1B/1D antagonist.
    Harrison AA, Parsons LH, Koob GF, Markou A.
    Psychopharmacology (Berl); 1999 Jan 08; 141(3):242-50. PubMed ID: 10027505
    [Abstract] [Full Text] [Related]

  • 58. 5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes.
    Pappert EJ, Goetz CG, Stebbins GT, Belden M, Carvey PM.
    Eur J Pharmacol; 1998 Apr 17; 347(1):51-6. PubMed ID: 9650847
    [Abstract] [Full Text] [Related]

  • 59. Functional effects of the 5-HT1D receptor antagonist GR 127,935 at human 5-HT1D alpha, 5-HT1D beta, 5-HT1A and opossum 5-HT1B receptors.
    Pauwels PJ, Palmier C.
    Eur J Pharmacol; 1995 Jul 18; 290(2):95-103. PubMed ID: 8575538
    [Abstract] [Full Text] [Related]

  • 60. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
    John GW, Pauwels PJ, Perez M, Halazy S, Le Grand B, Verscheure Y, Valentin JP, Palmier C, Wurch T, Chopin P, Marien M, Kleven MS, Koek W, Assie MB, Carilla-Durand E, Tarayre JP, Colpaert FC.
    J Pharmacol Exp Ther; 1999 Jul 18; 290(1):83-95. PubMed ID: 10381763
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.